HR 4820
99th Congress
House
Health
Consumer education
Consumer protection
Drug industry
Drug safety and regulation
Drugs
Drugs and narcotics
Foreign Trade and Investments
Government paperwork
Government records, documents, and information
Import restrictions
Imports
Licenses
Prescription Drug Marketing Act of 1986
Introduced: May 14, 1986
See on congress.gov
Everywhere this bill has been
7 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 7, 1986
Ordered to be Reported (Amended).
Oct 7, 1986
Committee Consideration and Mark-up Session Held.
Sep 23, 1986
Forwarded by Subcommittee to Full Committee (Amended).
Sep 23, 1986
Subcommittee Consideration and Mark-up Session Held.
May 22, 1986
Referred to Subcommittee on Health and the Environment.
May 14, 1986
Referred to House Committee on Energy and Commerce.
May 14, 1986
Introduced in House
Plain-English summary
Prescription Drug Marketing Act of 1986 - Amends the Federal Food, Drug, and Cosmetic Act to permit only the U.S. manufacturer of a drug to reimport such drug into the United States.
Prohibits the sale of prescription drug samples. Permits the distribution of samples only to practitioners licensed to prescribe such drugs. Requires such practitioners to return a receipt for such drug samples to the manufacturers to be kept and made available to Federal and State officials.
Requires drug wholesalers to provide drug purchasers with a statement identifying the manufacturer and each sale of the drug. Directs the Secretary of Health and Human Services to issue licensing standards for drug wholesalers.
What's happening now
Ordered to be Reported (Amended).
Committees of jurisdiction
2
Cosponsors
1